|
|
Prepublished online as a Blood First Edition Paper on February 27, 2003; DOI 10.1182/blood-2002-05-1504.

Submitted May 22, 2002
Accepted January 23, 2003
The human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR -chain
Jenny Odeberg, Bodo Plachter, Lars Branden, and Cecilia Soderberg-Naucler*
Departent of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
Institute for Virology, University of Mainz, Mainz, Germany
Clinical Research Center (CRC), Karolinska Institutet, Huddinge, Sweden
* Corresponding author; email: cecilia.soderberg.naucler{at}cmm.ki.se.
Human cytomegalovirus (HCMV) has developed multiple strategies to escape immune recognition. Here, we demonstrate that HCMV downregulates HLA-DR expression in infected IFN- stimulated fibroblasts at 1 day post infection. Decreased HLA-DR expression was not observed in cells infected with an HCMV strain lacking the pp65 gene (RVAD65), but in cells transfected with the pp65 gene. HLA-DR expression accumulated in vacuoles near the nucleus in HCMV infected, but not in uninfected or RVAD65 infected cells. In addition, the HLA-DR -chain, but not the [[beta]-chain or HLA-DM was degraded in HCMV infected, but not in RVAD65 infected cells. Thus, the HCMV protein pp65 mediates decreased expression of HLA-DR, by mediating an accumulation of HLA class II molecules in lysosmes that results in degradation of the HLA-DR- chain.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Chevillotte, S. Landwehr, L. Linta, G. Frascaroli, A. Luske, C. Buser, T. Mertens, and J. von Einem
Major Tegument Protein pp65 of Human Cytomegalovirus Is Required for the Incorporation of pUL69 and pUL97 into the Virus Particle and for Viral Growth in Macrophages
J. Virol.,
March 15, 2009;
83(6):
2480 - 2490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Baron and J.-L. Davignon
Inhibition of IFN-{gamma}-Induced STAT1 Tyrosine Phosphorylation by Human CMV Is Mediated by SHP2
J. Immunol.,
October 15, 2008;
181(8):
5530 - 5536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kessler, M. Reich, G. Jahn, E. Tolosa, A. Beck, H. Kalbacher, H. Overkleeft, S. Schempp, and C. Driessen
Human cytomegalovirus infection interferes with major histocompatibility complex type II maturation and endocytic proteases in dendritic cells at multiple levels
J. Gen. Virol.,
October 1, 2008;
89(10):
2427 - 2436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Kalejta
Tegument Proteins of Human Cytomegalovirus
Microbiol. Mol. Biol. Rev.,
June 1, 2008;
72(2):
249 - 265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rodriguez, L. Zoecklein, J. G. Kerkvliet, K. D. Pavelko, L. Papke, C. L. Howe, L. R. Pease, and C. David
Human HLA-DR Transgenes Protect Mice from Fatal Virus-Induced Encephalomyelitis and Chronic Demyelination
J. Virol.,
April 1, 2008;
82(7):
3369 - 3380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Wiertz, R. Devlin, H. L. Collins, and M. E. Ressing
Herpesvirus Interference with Major Histocompatibility Complex Class II-Restricted T-Cell Activation
J. Virol.,
May 1, 2007;
81(9):
4389 - 4396.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Lee, L. Hertel, R. K. Louie, T. Burster, V. Lacaille, A. Pashine, D. A. Abate, E. S. Mocarski, and E. D. Mellins
Human Cytomegalovirus Alters Localization of MHC Class II and Dendrite Morphology in Mature Langerhans Cells
J. Immunol.,
September 15, 2006;
177(6):
3960 - 3971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Odeberg, N. Wolmer, S. Falci, M. Westgren, A. Seiger, and C. Soderberg-Naucler
Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells.
J. Virol.,
September 1, 2006;
80(18):
8929 - 8939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Sinzger, K. Eberhardt, Y. Cavignac, C. Weinstock, T. Kessler, G. Jahn, and J.-L. Davignon
Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules
J. Gen. Virol.,
July 1, 2006;
87(7):
1853 - 1862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Trgovcich, C. Cebulla, P. Zimmerman, and D. D. Sedmak
Human Cytomegalovirus Protein pp71 Disrupts Major Histocompatibility Complex Class I Cell Surface Expression
J. Virol.,
January 15, 2006;
80(2):
951 - 963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Ressing, D. van Leeuwen, F. A. W. Verreck, S. Keating, R. Gomez, K. L. M. C. Franken, T. H. M. Ottenhoff, M. Spriggs, T. N. Schumacher, L. M. Hutt-Fletcher, et al.
Epstein-Barr Virus gp42 Is Posttranslationally Modified To Produce Soluble gp42 That Mediates HLA Class II Immune Evasion
J. Virol.,
January 15, 2005;
79(2):
841 - 852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Abate, S. Watanabe, and E. S. Mocarski
Major Human Cytomegalovirus Structural Protein pp65 (ppUL83) Prevents Interferon Response Factor 3 Activation in the Interferon Response
J. Virol.,
October 15, 2004;
78(20):
10995 - 11006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Jones and S.-W. Lee
An Acidic Cluster of Human Cytomegalovirus UL99 Tegument Protein Is Required for Trafficking and Function
J. Virol.,
February 1, 2004;
78(3):
1488 - 1502.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|